Physician
Hematology
Dr. Richard R. Kosierowski, MD
Doctor Richard R. Kosierowski, MD practices Hematology. He went to Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74/67 in Research/PrimaryCare. Richard Kosierowski is also a published physician. He has 6 publication published. The most recent publication is: Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas.
Publications
- Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC).
- Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas.
- Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung Cancer: a phase II study by the Fox Chase Cancer Center Network.
- Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas.
- Phase II study of topotecan in metastatic hormone-refractory prostate Cancer.
Schools
University of Medicine And Dentistry of New Jersey Robert Wood Johnson Medical School
Morristown Meml Hospital
Mt Sinai Hospital
Conditions Treated
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
Mount Sinai School of Medicine -
Rutgers Robert Wood Johnson Medical School